Thromboxane Production in Morbidly Obese Subjects
Francesca Graziani(Università Cattolica del Sacro Cuore), Filippo Crea(Università Cattolica del Sacro Cuore), Amerigo Iaconelli(Università Cattolica del Sacro Cuore), Pio Cialdella(Università Cattolica del Sacro Cuore), Geltrude Mingrone(Università Cattolica del Sacro Cuore), Giovanna Liuzzo(Università Cattolica del Sacro Cuore), Roberta Della Bona(Ospedale Policlinico San Martino), Fabio M. Pulcinelli(Sapienza University of Rome), Simona Giubilato(Università Cattolica del Sacro Cuore), Luigi M. Biasucci(Agostino Gemelli University Polyclinic)
Cited by 45
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetologia|2022|986
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
|Diabetes Care|2016|969
Aspirin resistance: position paper of the Working Group on Aspirin Resistance
|Journal of Thrombosis and Haemostasis|2005|329